このアイテムのアクセス数: 279
このアイテムのファイル:
| ファイル | 記述 | サイズ | フォーマット | |
|---|---|---|---|---|
| 13_423.pdf | 520.07 kB | Adobe PDF | 見る/開く |
完全メタデータレコード
| DCフィールド | 値 | 言語 |
|---|---|---|
| dc.contributor.author | 新島, 端夫 | ja |
| dc.contributor.author | 浅野, 美智雄 | ja |
| dc.contributor.alternative | NIIJIMA, Tadao | en |
| dc.contributor.alternative | ASANO, Michio | en |
| dc.date.accessioned | 2010-05-24T05:56:08Z | - |
| dc.date.available | 2010-05-24T05:56:08Z | - |
| dc.date.issued | 1967-05 | - |
| dc.identifier.issn | 0018-1994 | - |
| dc.identifier.uri | http://hdl.handle.net/2433/113142 | - |
| dc.description.abstract | The results of clinical investigation on the new long acting cholinesterase inhibitor "Ubretid" showed that it could be employed for tornicising the bladder and ureteral musculature. Clinical improvements of symptoms and signs including cystometrograms were observed in 7 of 8 patients with mild bladder neck sclerosis, 5 of 8 patients with neurogenic bladder dysfunction and 1 of 4 patients with vesicoureteral reflux. A dose of 5 mg. (one tablet) once a day by mouth seemed to be adequate. Maintenance on 5 mg. every other day may be desirable in chronic cases. No marked by-effects such as intestinal spasms, vomiting, excessive sweating, increased saliva secretion, muscular fasciculation and cholinergic crisis were encountered in this study. | en |
| dc.format.mimetype | application/pdf | - |
| dc.language.iso | jpn | - |
| dc.publisher | 京都大学医学部泌尿器科学教室 | ja |
| dc.publisher.alternative | Department of Urology, Faculty of Medicine, Kyoto Univeersity | en |
| dc.subject | Adult | en |
| dc.subject | Aged | en |
| dc.subject | Cholinesterase Inhibitors/therapeutic use | en |
| dc.subject | Female | en |
| dc.subject | Humans | en |
| dc.subject | Male | en |
| dc.subject | Middle Aged | en |
| dc.subject | Prostatic Diseases/drug therapy | en |
| dc.subject | Urinary Bladder, Neurogenic/drug therapy | en |
| dc.subject | Vesico-Ureteral Reflux/drug therapy | en |
| dc.subject.ndc | 494.9 | - |
| dc.title | 泌尿器科領域における抗コリンエステラーゼ剤Ubretidの使用経験 | ja |
| dc.title.alternative | Clinical appraisal of Ubretid : a new cholinesterase inhibitor | en |
| dc.type | departmental bulletin paper | - |
| dc.type.niitype | Departmental Bulletin Paper | - |
| dc.identifier.ncid | AN00208315 | - |
| dc.identifier.jtitle | 泌尿器科紀要 | ja |
| dc.identifier.volume | 13 | - |
| dc.identifier.issue | 5 | - |
| dc.identifier.spage | 423 | - |
| dc.identifier.epage | 428 | - |
| dc.textversion | publisher | - |
| dc.sortkey | 08 | - |
| dc.address | 東京大学医学部泌尿器科学教室 | ja |
| dc.address | 東京大学医学部泌尿器科学教室 | ja |
| dc.address.alternative | the Department of Urology, Faculty of Medicine, the University of Tokyo | en |
| dc.address.alternative | the Department of Urology, Faculty of Medicine, the University of Tokyo | en |
| dc.identifier.pmid | 5624432 | - |
| dcterms.accessRights | open access | - |
| dc.identifier.pissn | 0018-1994 | - |
| dc.identifier.jtitle-alternative | Acta urologica Japonica | la |
| dc.identifier.jtitle-alternative | Hinyokika Kiyo | en |
| 出現コレクション: | Vol.13 No.5 | |
このリポジトリに保管されているアイテムはすべて著作権により保護されています。